32M Fin 2 years + Min/Derma 2 months 9/27/2026
Similar Community Posts Join
5 / 5 resultscommunity 32M, dealing with hair loss since 2010 (AGA + seb derm). Started treatment 11 months ago: Progress was slow but steady. Still shedding 60–80 hairs/day, but density improved.
A 32-year-old male has been dealing with hair loss since 2010 and started treatment 11 months ago. He used dutasteride, finasteride, minoxidil, multivitamins, vitamin D3, PRP, and a laser cap, resulting in improved hair density despite ongoing shedding.
community Derm stopped me from using Minoxidal
A dermatologist advised stopping minoxidil due to heavy shedding, suggesting alternative treatments like Betaval Lotion and supplements, but many users disagreed, recommending continuing minoxidil and adding finasteride for better results. The conversation highlights skepticism about the dermatologist's motives and emphasizes the importance of understanding the type of hair loss before choosing treatments.
community Just popped my first fin, excited as hell!
A user shared their excitement about starting finasteride for hair loss after trying various ineffective methods. Other users discussed their experiences with finasteride, including shedding phases and side effects, with one mentioning using topical finasteride and minoxidil.
community Finasteride doubled my testosterone & estrogen
Finasteride increased testosterone and estrogen, stopped hair loss, and promoted regrowth. Users discussed side effects like libido changes and considered adding minoxidil and aromatase inhibitors.
community Microneedling + topical minoxidil is the most underrated combo.
Microneedling with topical minoxidil is effective for hair regrowth, especially with finasteride. Users report fewer side effects compared to oral minoxidil.
Related Research
6 / 6 resultsresearch Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin-like growth factor-I production in dermal papillae
In this study, DHT was found to inhibit hair growth in mice by decreasing IGF-I production in dermal papillae through reduced sensory neuron stimulation.
research Cyclohex-1-ene Carboxylic Acids: Synthesis and Biological Evaluation of Novel Inhibitors of Human 5α Reductase
This study reported that newly synthesized nonsteroidal compounds were effective at inhibiting prostatic 5 alpha reductase isozyme 2, especially the compound with an N, N-diisopropylcarbamoyl substituent, suggesting potential for treating benign prostatic hyperplasia.
research In vitro 5α-reductase inhibition by selected Ayurvedic herbs for androgenic disorders
This study evaluated the 5α-reductase inhibitory effects of several Ayurvedic herbs and found that Eclipta alba exhibited the highest activity, suggesting its potential for use in treatments for androgenic disorders like alopecia.
research Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report
This study found that cyclosporine-A might significantly increase the risk of cerebral venous and arterial thrombosis in patients with aplastic anemia.
research STIM1 R304W in mice causes subgingival hair growth and an increased fraction of trabecular bone
This study found that a mutation causing Stormorken syndrome in mice led to skeletal abnormalities and unusual hair growth, showcasing the STIM1 R304W protein’s role in bone development and cell fate.
research Granules of finasteride and cyclodextrin obtained by hot-melt extrusion to target the hair follicles
This study developed finasteride-containing granules using a method that improved follicular targeting for androgenic alopecia and reported potential for easy industrial production.